Formosa Pharmaceuticals Investors
Financials
Consolidated Financial Statements
News Highlight
Formosa Pharmaceuticals and China Grand Pharmaceutical and Healthcare Holdings Limited enter into licensing agreement for APP13007
2021-06-03
(Corticosteroid for inflammation and pain after cataract surgery) TAIPEI – June 3, 2021 – Formosa Pharmaceuticals (“Formosa”, stock code:6838), a subsidiary of Formosa Laboratories (TWSE stock code:4746), and China Grand
